Axa S.A. Madrigal Pharmaceuticals, Inc. Transaction History

Axa S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$58.39 - $296.54 $75,907 - $385,502	1,300 New	1,300 $377,000
Q1 2019 May 14, 2019	SELL	$103.48 - $143.84 $476,008 - $661,664	-4,600 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$94.77 - $215.54 $161,109 - $366,418	-1,700 Reduced 26.98%	4,600 $519,000
Q2 2018 Aug 13, 2018	BUY	$101.55 - $313.9 $639,765 - $1.98 Million	6,300 New	6,300 $1.76 Million

298

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.32B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.